logo
[breadcrumb_custom]

Tag: Pieris Pharmaceuticals Inc.
Stock

Pieris Pharmaceuticals Inc (PIRS) Stock: From Low to High in 52 Weeks

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Pieris Pharmaceuticals Inc’s current trading price is -87.95% away from its 52-week high, while its distance from the 52-week low is 34.61%. The stock’s price range for this period has been between $0.14 and $1.52 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.4 million for the day, a number notably lower than the average daily volume of 0.61 million over the last three months. The market performance of Pieris Pharmaceuticals Inc’s
Finance

PIRS Stock Update: Pieris Pharmaceuticals Inc’s Banking’s Market Struggles and Potential Opportunities

Pieris Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $1.52 on 03/28/23, while the lowest value for the same period was recorded at $0.14 on 12/13/23. 52-week price history of PIRS Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Pieris Pharmaceuticals Inc’s current trading price is -88.04% away from its 52-week high, while its distance from the 52-week low is 33.58%. The stock’s price range during the 52-week period has remained between $0.14

TOST Stock
Industry

Pieris Pharmaceuticals Inc (PIRS) Stock: Navigating Drops and Gains

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Pieris Pharmaceuticals Inc’s current trading price is -86.18% away from its 52-week high, while its distance from the 52-week low is 54.30%. The stock’s price range during this period has varied between $0.14 and $1.52. The company, active in the Healthcare sector, saw a trading volume of around 9.43 million for the day, considerably higher average daily volume of 0.39 million observed over the last three months. The market performance of Pieris Pharmaceuticals Inc has

Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.
Facebook-f Twitter Google-plus-g Pinterest

Quick Links

Categories

©Fueled By Smart TechOne